X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

EPMA Journal

期刊標題檢索 EPMA J 最新評論: How to add PPPM content to share? (2024-01-23)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[EPMA Journal]您好,您是該頁面的第 6239 位訪客。

期刊簡介
期刊名稱EPMA Journal EPMA Journal
LetPub Score
6.9
50 ratings
Rate

Reputation
8.0

Influence
5.9

Speed
7.0

期刊簡稱EPMA J
ISSN1878-5085
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
12.501.3701.163
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Health Policy
Q18 / 310
Category: Medicine
Subcategory: Biochemistry (medical)
Q16 / 72
Category: Medicine
Subcategory: Drug Discovery
Q114 / 157

自引率 (2023-2024)26.70%自引率趨勢
掲載範囲
PMA Journal is a journal of predictive, preventive and personalized medicine (PPPM). The journal provides expert viewpoints and research on medical innovations and advanced healthcare using predictive diagnostics, targeted preventive measures and personalized patient treatments. The journal is indexed by PubMed, Embase and Scopus.
官方網站https://www.springer.com/13167
在線稿件提交https://www.editorialmanager.com/epmj
開放訪問Yes
出版商Springer International Publishing
主題領域Medicine
出版國/地區United Kingdom
發行頻率年4回刊行
創刊年2010
每年文章數39每年文章數趨勢
黃金OA百分比50.00%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ130/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1878-5085%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【EPMA Journal】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    EPMA JournalH-index: 26

    CiteScore: 12.50
    Non-coding RNA ResearchH-index: 0

    CiteScore: 7.70
    Chemical Biology LettersH-index: 0

    CiteScore: 8.00
    Current Chemical BiologyH-index: 0

    CiteScore: 1.40
    Journal of Circulating BiomarkersH-index: 0

    CiteScore: 3.20
    Electronic Journal of the International Federation of Clinical Chemistry and Laboratory MedicineH-index: 0

    CiteScore: 2.30
    Life MetabolismH-index: 0

    CiteScore: 1.10
    學科內最受檢索的期刊 頁面查看次數
    EPMA Journal17477
    Non-coding RNA Research5892
    Current Chemical Biology2799
    Electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine1773
    Chemical Biology Letters1728
    Journal of Circulating Biomarkers1565
    Life Metabolism838
  •  

    EPMA Journal EPMA Journal
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [EPMA Journal] 的評論撰寫評論
作者: 一条小访梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-23 09:57:01 評論於
How to add PPPM content to share?
(1) 讚! | 一条小访梦

作者: 逍遥建明


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-20 09:59:30 評論於
What happened later?
(0) 讚! | 逍遥建明

作者: 之槐小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-21 16:10:24 評論於
I keep getting rejected, saying that I must submit a declaration, but the manuscript already includes it. Do you know how to proceed?
(0) 讚! | 之槐小娘子

作者: 亚瑟参孙


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-14 20:47:44 評論於
This submission requires a lot of PPPM content. In case it is rejected after review, submitting to another magazine would mean having to revise it all over again, as there are no other magazines with full PPPM content
(0) 讚! | 亚瑟参孙

作者: 月河海霞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-27 16:08:51 評論於
The official website says that the first decision will be made within 5 days. I submitted mine on the 22nd, and it's already the 29th today, but it's still showing as "Editor Assigned."
(0) 讚! | 月河海霞

作者: 雅惠小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-12 20:05:37 評論於
What does it mean?
(0) 讚! | 雅惠小娘子

作者: 孤云华茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-08 18:17:55 評論於
However, it should be noted that this is a special issue of the SI magazine. At first glance, it is not apparent, but the core is based on special issue material from the past four to five years
(0) 讚! | 孤云华茂

作者: 孤云华茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-02 09:47:30 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 5.0
Experience sharing: High-quality journals in the field of PPPM have high requirements. If you have innovative articles and conduct research under the PPPM framework, you can give it a try!
(0) 讚! | 孤云华茂

作者: 初真小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-23 12:38:28 評論於
Review Speed: 3.0 | Submission Hit Rate: 75.0 Emphasis on Research Direction: Metabolomics; Ophthalmology Experience Sharing: A review on metabolomics was submitted in November. After receiving comments from two editors, it was quickly returned for review. The attitude was positive, and it was accepted quickly after revisions. It was accepted in January, but it could have been faster if I didn't delay for a few days due to personal reasons. Overall, it was still good
(0) 讚! | 初真小公主

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 19:11:40 評論於
Journals in the research field that are considered to have higher quality in terms of manuscript acceptance or are developing towards better quality are more recognized. Considerations may also include acceptance rate and review speed when time constraints are a factor
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:24:55 評論於
Please translate the following paragraph into English and Japanese, and use ":" and ":" as titles
(0) 讚! | 维尔娜菲茨杰拉德

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 17:26:22 評論於
Should we choose both well-established journals and newly published journals?
(0) 讚! | 平原文波

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 16:41:40 評論於
Two journals are quite similar, how to choose which one to submit to?
(0) 讚! | 深渊兴业

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [EPMA Journal] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*